Quaternary ammonium compounds

   
   

Novel quaternary ammonium compounds of the formula ##STR1##

and any stereoisomers thereof, wherein R1, R2 and R3 independently represent C1-C6 alkyl, optionally substituted with phenyl or hydroxyl, or both, and wherein any two of R1, R2 and R3 may form a ring together with the quaternary ammonium nitrogen; R4 represents H, CH3, or COR4-1, wherein R4-1 represents (C1-C4 alkyl), (C1-C4 alkoxy), or NR4-2R4-3, wherein R4-2 and R4-3 independently represent H or (C1-C4 alkyl); R5, R6 and R7 independently represent H, OCH3, OH, CONH2, SO2NH2, F, Cl, Br, I, CF3, or (C1-C4 alkyl), optionally substituted with one or two OH, (C1-C4 alkoxy), COOH, or COO(C1-C3 alkyl); and X- represents an anion of a pharmaceutically acceptable acid, the compounds for use as medicaments, use of the compounds for the manufacture of specific medicaments, and pharmaceutical compositions comprising the compounds. The present invention also concerns a method of treatment involving administration of the compounds.

 
Web www.patentalert.com

< Secreted protein HEMAE80

< Catalyst to improve the color stability of N,N-dialkylalkanolamines

> Death domain containing receptor 5

> 5-chloro-3-(4-methanesulfonylphenyl)-6'-methyl-[2,3]bipyridinyl in pure crystalline form and process for synthesis

~ 00179